Valiant Organics reported a strong Q1-FY27, with revenue reaching 231.5 Cr, a 13.3% YoY jump and its highest in six quarters, signaling a full recovery from previous troughs.

Profit After Tax (PAT) soared to 29.3 Cr, with PAT margins expanding to 12.66%. The company focuses on specialty chemicals crucial for pharmaceuticals, dyes, and agrochemicals.

Key chemistries like Hydrogenation (54% of revenue) and Ammonolysis (21%) drive sales.

Strategic strengths include diverse products, integrated operations, and robust supply chains.

Operational efficiency was a highlight: gross profit margins improved to 43% (from 39% YoY) due to lower raw material costs.

EBITDA margins expanded to 17.97%, boosted by operating leverage and controlled employee expenses, even with 14% revenue growth.

Finance costs also dropped by 15% YoY.

EPS stood at ₹10.44 per share.